Prospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 14, 2014; 20(42): 15820-15829
Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15820
Table 2 Multivariate analysis of disease-free survival
VariableMain cohort
External reference cohort
HR (95%CI)P valueHR (95%CI)P value
Type of response after CRT
ypT0N00.07 (0.01-0.54)0.01000.51 (0.15-1.7)0.2700
ypT1-2N00.16 (0.06-0.46)0.00070.41 (0.18-0.94)0.0360
ypT3-4/N1-2ReferenceReference
CEA1.02 (1.01-1.03)0.00101.02 (1.01-1.03)0.0072
Pre-surgery clinical stage
T2-3N0ReferenceReference
T4 and/or N11.19 (0.82-1.73)0.35001.66 (0.85-3.26)0.1400
Admission stay after surgery1, d1.02 (1.01-1.02)0.0020

  • Citation: García-Albéniz X, Gallego R, Hofheinz RD, Fernández-Esparrach G, Ayuso-Colella JR, Bombí JA, Conill C, Cuatrecasas M, Delgado S, Ginés A, Miquel R, Pagés M, Pineda E, Pereira V, Sosa A, Reig O, Victoria I, Feliz L, María de Lacy A, Castells A, Burkholder I, Hochhaus A, Maurel J. Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation. World J Gastroenterol 2014; 20(42): 15820-15829
  • URL: https://www.wjgnet.com/1007-9327/full/v20/i42/15820.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v20.i42.15820